Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 368 participants.

Also called NCT04916197

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 368 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04916197
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04916197. Randomized; no masking; primary purpose prevention. Start 2024-03-01 (anticipated); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET)
Condition
Acute Ischemic Stroke
Intervention (Drug)
Dexmedetomidine prolonged sedation
Intervention (Drug)
0.9% saline
Lead sponsor
Beijing Chao Yang Hospital (class: other)

Record details

Record id
cardio:ct-nct04916197
Content hash
f862ae979578e8e69b80ed92ca5f7445a8f72a90239d513244ba566e41819ff6